P-078 Neoadjuvant epirubicin, oxaliplatin and capecitabine (EOX) in locally advanced resectable gastroesophageal junction and gastric adenocarcinoma: the experience in our institution

類似資料

• Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX)
  著者:: Wang, Yan, 等
  出版事項: (2016)
• Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
  著者:: Di Lauro, Luigi, 等
  出版事項: (2009)
• A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer
  著者:: Bozkaya, Yakup, 等
  出版事項: (2018)
• Endoscopic resection for esophageal or gastroesophageal junction adenocarcinoma
  著者:: Harada, Kazuto, 等
  出版事項: (2019)
• Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  著者:: Tian, Yuan, 等
  出版事項: (2021)